| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antifungal agents: unapproved uses, dosages, or indications
|
Sehgal, Virendra N
|
|
2002
|
20 |
5 |
p. 481-489
9 p.
|
article
|
| 2 |
Anti-TNF therapies—the hope of tomorrow
|
Wolf, Ronni
|
|
2002
|
20 |
5 |
p. 522-530
9 p.
|
article
|
| 3 |
Antiviral drugs: unapproved uses, dosages, or indications
|
Rebora, Alfredo
|
|
2002
|
20 |
5 |
p. 474-480
7 p.
|
article
|
| 4 |
Commentary: unapproved uses, dosages, or indications in dermatology: a physician’s reference
|
Wolf, Ronni
|
|
2002
|
20 |
5 |
p. 465-466
2 p.
|
article
|
| 5 |
Complementary medicine in dermatology
|
Millikan, Larry E
|
|
2002
|
20 |
5 |
p. 602-605
4 p.
|
article
|
| 6 |
Complementary psychotherapy in dermatology: hypnosis and biofeedback
|
Shenefelt, Philip D
|
|
2002
|
20 |
5 |
p. 595-601
7 p.
|
article
|
| 7 |
Cryosurgery: unapproved uses, dosages, or indications
|
Dawber, Rodney
|
|
2002
|
20 |
5 |
p. 563-570
8 p.
|
article
|
| 8 |
Interferons: unapproved uses, dosages, or indications
|
Orion, Edith
|
|
2002
|
20 |
5 |
p. 493-504
12 p.
|
article
|
| 9 |
Management of toe onychomycosis: what is the potential for improving efficacy of treatment? a 1 Edited by Stephen P. Stone
|
Gupta, Aditya K
|
|
2002
|
20 |
5 |
p. 607-609
3 p.
|
article
|
| 10 |
Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications
|
Wolf, Ronni
|
|
2002
|
20 |
5 |
p. 547-557
11 p.
|
article
|
| 11 |
Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications
|
Wolf, Ronni
|
|
2002
|
20 |
5 |
p. 531-546
16 p.
|
article
|
| 12 |
New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications
|
Assmann, Till
|
|
2002
|
20 |
5 |
p. 505-514
10 p.
|
article
|
| 13 |
Photodynamic therapy: unapproved uses, dosages, or indications
|
Salva, Katrin A
|
|
2002
|
20 |
5 |
p. 571-581
11 p.
|
article
|
| 14 |
Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications
|
Koo, John Y
|
|
2002
|
20 |
5 |
p. 582-594
13 p.
|
article
|
| 15 |
The role of the pharmaceutical industry in drug development in dermatology
|
Cauwenbergh, Geert
|
|
2002
|
20 |
5 |
p. 467-473
7 p.
|
article
|
| 16 |
Topical corticosteroids: unapproved uses, dosages, or indications
|
Lagos, Beatriz R
|
|
2002
|
20 |
5 |
p. 490-492
3 p.
|
article
|
| 17 |
Topical immunotherapy: unapproved uses, dosages, or indications
|
Higgins, Elisabeth
|
|
2002
|
20 |
5 |
p. 515-521
7 p.
|
article
|
| 18 |
Topical vitamin D3 analogues: unapproved uses, dosages, or indications
|
Parish, Jennifer L
|
|
2002
|
20 |
5 |
p. 558-562
5 p.
|
article
|
Journal description